{"log_id": 3861465133171794982, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 6e-06, "average": 0.998453, "min": 0.989351}, "location": {"width": 831, "top": 135, "height": 57, "left": 172}, "words": "多数未予治疗,给予治疗者中多数接受局部用药,例如糖皮质激素或者口服抗组胺药"}, {"probability": {"variance": 2.2e-05, "average": 0.998008, "min": 0.975242}, "location": {"width": 851, "top": 184, "height": 58, "left": 171}, "words": "除此之外,部分患者还出现注射部位反应再现,即在最近一次的注射点有皮肤反应同时"}, {"probability": {"variance": 0, "average": 0.999972, "min": 0.999945}, "location": {"width": 38, "top": 135, "height": 119, "left": 1161}, "words": "食附"}, {"probability": {"variance": 5.9e-05, "average": 0.91551, "min": 0.907835}, "location": {"width": 57, "top": 179, "height": 31, "left": 1149}, "words": "药品"}, {"probability": {"variance": 6e-06, "average": 0.999265, "min": 0.984658}, "location": {"width": 852, "top": 235, "height": 56, "left": 171}, "words": "在多数的先前注射点也出现注射部位反应。这种反应一般为一过性的,而且治疗后不再"}, {"probability": {"variance": 0, "average": 0.999334, "min": 0.99889}, "location": {"width": 48, "top": 312, "height": 28, "left": 173}, "words": "复发"}, {"probability": {"variance": 2e-06, "average": 0.999074, "min": 0.99218}, "location": {"width": 809, "top": 334, "height": 57, "left": 217}, "words": "在斑块型银屑病患者中进行的对照试验表明,在给药的前12周内依那西普治疗组"}, {"probability": {"variance": 0.004835, "average": 0.985997, "min": 0.587292}, "location": {"width": 683, "top": 390, "height": 52, "left": 173}, "words": "患者中约有14.5%,安慰剂治疗组中约有5.2%出现注射部位局部反应"}, {"probability": {"variance": 0.00012, "average": 0.996707, "min": 0.941509}, "location": {"width": 612, "top": 441, "height": 48, "left": 220}, "words": "上市后曾观察到与依那西普治疗有关的注射部位的出血和瘀血"}, {"probability": {"variance": 0, "average": 0.999617, "min": 0.998898}, "location": {"width": 89, "top": 511, "height": 26, "left": 175}, "words": "严重感染"}, {"probability": {"variance": 9e-06, "average": 0.998942, "min": 0.981916}, "location": {"width": 812, "top": 533, "height": 54, "left": 219}, "words": "在类风湿关节炎患者的对照试验中,当依那西普治疗组和安慰剂组的治疗暴露时间"}, {"probability": {"variance": 0.000728, "average": 0.993803, "min": 0.831532}, "location": {"width": 858, "top": 581, "height": 58, "left": 176}, "words": "相同时,两组报告严重感染(致命的、威胁生命的、需要住院的或需要抗生素静脉给药"}, {"probability": {"variance": 0.000211, "average": 0.996286, "min": 0.91047}, "location": {"width": 857, "top": 631, "height": 57, "left": 176}, "words": "的)和非严重感染的发生率相当。最常见的非严重感染是上呼吸道感染。依那西普治疗"}, {"probability": {"variance": 0.00014, "average": 0.996311, "min": 0.939138}, "location": {"width": 854, "top": 680, "height": 56, "left": 175}, "words": "达48个月的类风湿关节炎患者中出现严重感染的比例为6.3%,包括脓肿(各种部位)"}, {"probability": {"variance": 0.00448, "average": 0.986466, "min": 0.587108}, "location": {"width": 843, "top": 730, "height": 54, "left": 177}, "words": "菌血症、支气管炎、滑麋炎、蜂窝组织炎、胆囊炎、腹泻、憩室炎、心内膜炎(疑似)"}, {"probability": {"variance": 9e-06, "average": 0.999135, "min": 0.98128}, "location": {"width": 845, "top": 778, "height": 56, "left": 176}, "words": "胃肠炎、乙型肝炎、带状疱疹、小腿溃疡、口腔感染、骨髓炎、耳炎、腹膜炎、肺炎"}, {"probability": {"variance": 1e-06, "average": 0.999433, "min": 0.994832}, "location": {"width": 862, "top": 825, "height": 58, "left": 177}, "words": "肾盂肾炎、脓毒血症、脓毒性关节炎、鼻窦炎、皮肤感染、皮肤溃疡、尿道感染、血管"}, {"probability": {"variance": 8.3e-05, "average": 0.997192, "min": 0.942602}, "location": {"width": 862, "top": 875, "height": 57, "left": 177}, "words": "炎以及伤口感染等。在为期2年的活性对照试验中分别给予受试者依那西普、甲氨蝶呤"}, {"probability": {"variance": 5e-06, "average": 0.998462, "min": 0.991912}, "location": {"width": 863, "top": 923, "height": 58, "left": 179}, "words": "或依那西普与甲氨蝶呤联用,三个治疗组发生严重感染的发生率相似,但不能排除依那"}, {"probability": {"variance": 2.4e-05, "average": 0.997611, "min": 0.979596}, "location": {"width": 461, "top": 986, "height": 42, "left": 179}, "words": "西普与甲氨蝶呤联用与感染发生率的增加有关"}, {"probability": {"variance": 4e-06, "average": 0.998724, "min": 0.989896}, "location": {"width": 822, "top": 1021, "height": 56, "left": 223}, "words": "在斑块型银屑病患者中进行的24周安慰剂对照试验中,依那西普治疗组与安慰剂"}, {"probability": {"variance": 1.3e-05, "average": 0.99881, "min": 0.977869}, "location": {"width": 863, "top": 1070, "height": 55, "left": 180}, "words": "治疗组的感染发生率相似。依那西普治疗组患者出现的严重感染包括:蜂窝组织炎、胃"}, {"probability": {"variance": 1e-06, "average": 0.999438, "min": 0.996399}, "location": {"width": 866, "top": 1118, "height": 55, "left": 180}, "words": "肠炎、肺炎、胆囊炎、骨髓炎、胃炎、阑尾炎、链球菌导致的筋膜炎、肌炎、脓毒血症"}, {"probability": {"variance": 4e-05, "average": 0.997231, "min": 0.963185}, "location": {"width": 864, "top": 1167, "height": 55, "left": 180}, "words": "性休克、憩室炎、以及脓肿。在双盲开放标签的银屑病关节炎试验中,1例患者报告严"}, {"probability": {"variance": 6.3e-05, "average": 0.996163, "min": 0.975222}, "location": {"width": 157, "top": 1239, "height": 31, "left": 181}, "words": "重感染(肺炎)。"}, {"probability": {"variance": 1.7e-05, "average": 0.997966, "min": 0.980512}, "location": {"width": 823, "top": 1267, "height": 51, "left": 225}, "words": "曾有使用依那西普发生严重和致命感染的报告,报告的病原包括细菌、分枝杆菌(含"}, {"probability": {"variance": 4.1e-05, "average": 0.996215, "min": 0.97853}, "location": {"width": 223, "top": 1333, "height": 35, "left": 181}, "words": "结核病)、病毒和真菌"}, {"probability": {"variance": 1e-06, "average": 0.999352, "min": 0.995906}, "location": {"width": 601, "top": 1315, "height": 45, "left": 449}, "words": "些病例发生于开始使用依那西普治疗后的数周内,这些患者"}, {"probability": {"variance": 1.9e-05, "average": 0.998164, "min": 0.975083}, "location": {"width": 872, "top": 1364, "height": 53, "left": 180}, "words": "除了类风湿关节炎之外还患有基础疾病(糖尿病、充血性心力衰竭、活动性或慢性感染)"}, {"probability": {"variance": 0.000167, "average": 0.996131, "min": 0.918722}, "location": {"width": 858, "top": 1414, "height": 52, "left": 193}, "words": "(参见“注意事项”)。一项临床试验表明,依那西普治疗可能增加患有脓毒血症患者的"}, {"probability": {"variance": 0, "average": 0.999552, "min": 0.998756}, "location": {"width": 67, "top": 1486, "height": 27, "left": 183}, "words": "死亡率"}, {"probability": {"variance": 1e-06, "average": 0.999298, "min": 0.995261}, "location": {"width": 826, "top": 1512, "height": 53, "left": 226}, "words": "曾有机会致病菌感染的报告,包括侵袭性真菌感染、原虫感染、细菌感染(包括利"}, {"probability": {"variance": 0.000187, "average": 0.995832, "min": 0.931585}, "location": {"width": 861, "top": 1560, "height": 54, "left": 181}, "words": "斯塔氏菌属和军团病杆菌属)以及非典型分枝杆菌感染。在一项综合的临床试验数据中"}, {"probability": {"variance": 1e-06, "average": 0.998399, "min": 0.997266}, "location": {"width": 169, "top": 1609, "height": 34, "left": 802}, "words": "第7页共31页"}, {"probability": {"variance": 1e-06, "average": 0.999343, "min": 0.998266}, "location": {"width": 66, "top": 1632, "height": 26, "left": 183}, "words": "版本号"}], "language": 3}